Results 151 to 160 of about 563,890 (226)

Cyclooxygenases in pancreatic ductal adenocarcinoma: are they inflammatory catalysts for tumor growth. [PDF]

Front Oncol
Orhan A, Orhan T, Raskov H, Gögenur I.
europepmc   +1 more source

Platelet Drp1 phosphorylation provides a platform for immune-based platelet function testing. [PDF]

Blood
Barrios DA, Guo S, Powers M, Koseoglu S, Zerbey S, Lu R, Cermak A, Vayne C, Khan S, Aisiku O, Urman A, Thomas J, Patell R, Zwicker JI, Flaumenhaft R.   +14 more
europepmc   +1 more source

Chronic bisphenol A exposure at LOAEL induces hepatic metabolic remodeling associated with NAFLD-related pathways and hepatocarcinogenic susceptibility. [PDF]

Metabolomics
Lepiarczyk E, Wiszpolska M, Maździarz MA, Makowska K, Gonkowski S, Kaleczyc J, Majewska M.   +6 more
europepmc   +1 more source

Platelets as regulators of anti-tumor immunity: mechanisms and clinical implications. [PDF]

Cancer Metastasis Rev
Schlesinger M.
europepmc   +1 more source

Insulin Resistance and Platelet Hyperactivity: Hematological Insights and Nutritional Strategies for Vascular Protection. [PDF]

Nutrients
Mohammadian K, Basirian N, Fakhar F, Keramat S, Stanek A.   +4 more
europepmc   +1 more source

Thrombaxane-B2 as a predictor marker of atrial fibrillation. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Petramala L, Carnevale R, Marino L, D'Ambrosio L, Bartimoccia S, D'Amico EA, Picchio V, Leonardo A, Dietrich E, Forte M, Frati G, Galardo G, Circosta F, Sciarretta S, Letizia C.   +14 more
europepmc   +1 more source

Systemic metabolic dysfunction drives platelet-mediated inflammation, fibrogenesis, and hepatocarcinogenesis in metabolic dysfunction-associated steatotic liver disease. [PDF]

Clin Mol Hepatol
Ye B, Xu C.
europepmc   +1 more source

Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy. [PDF]

Res Pract Thromb Haemost
Kartika T, Buitrago L, Li J, Cunningham-Rundles C, Coller BS.   +4 more
europepmc   +1 more source

Structural and dynamic insights into agonist recognition and function of the thromboxane A₂ receptor. [PDF]

Nat Commun
Krawinski P, Matzov D, Ryder A, Lal K, Karlov DS, Chalhoub G, Mulvaney EP, Kinsella BT, McCormick PJ, Caffrey M, Tikhonova IG, Shalev-Benami M.   +11 more
europepmc   +1 more source

Microthrombi and hypercoagulability's contribution to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. [PDF]

J Cereb Blood Flow Metab
Wroe WW, Zeineddine HA, Blackburn SL, Aronowski J, McBride DW.   +4 more
europepmc   +1 more source